These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3525439)

  • 1. Enzymatic semisynthesis of porcine despentapeptide (B26-30) insulin using unprotected desoctapeptide (B23-30) insulin as a substrate. Model studies.
    Kubiak T; Cowburn D
    Int J Pept Protein Res; 1986 May; 27(5):514-21. PubMed ID: 3525439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypsin-catalysed formation of pig des-(23-63)-proinsulin from desoctapeptide-(B23-30)-insulin.
    Kubiak T; Cowburn D
    Biochem J; 1986 Mar; 234(3):665-70. PubMed ID: 3521594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of semisynthetic insulin analogues from bis(tert-butyloxycarbonyl)-desoctapeptide-insulin phenylhydrazide: importance of the aromatic region B24-B26.
    Riemen MW; Pon LA; Carpenter FH
    Biochemistry; 1983 Mar; 22(6):1507-15. PubMed ID: 6340739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and activity of insulin, XV[1-5]. Further evidence for the importance of arginine residue B22 in the activity of insulin. Semisyntheses of despentapeptide-(B23 - 30)-insulins varied in B22 using desnonapeptide-(B22 - 30)-insulin and tetrapeptides.
    Weitzel G; Bauer FU; Rehe Z
    Hoppe Seylers Z Physiol Chem; 1977 Dec; 358(12):1573-82. PubMed ID: 590940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-assisted semisynthesis of shortened B26-modified insulins.
    Sievert D; Gattner HG; Lenz V; Höcker H
    Biomed Biochim Acta; 1991; 50(10-11):S197-200. PubMed ID: 1820045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin.
    Tager H; Thomas N; Assoian R; Rubenstein A; Saekow M; Olefsky J; Kaiser ET
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3181-5. PubMed ID: 6997872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies on the three-step-increase in activity due to the aromatic amino acids B24-26 (-Phe-Phe-Tyr-).
    Weitzel G; Bauer FU; Eisele K
    Hoppe Seylers Z Physiol Chem; 1976 Feb; 357(2):187-200. PubMed ID: 1254246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramolecular enzymatic peptide synthesis: trypsin-mediated coupling of the peptide bond between B22-arginine and B23-glycine in a split crosslinked insulin.
    Chu SC; Wang CC; Brandenburg D
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):647-54. PubMed ID: 7024086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
    Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
    Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function relationships of des-(B26-B30)-insulin.
    Spoden M; Gattner HG; Zahn H; Brandenburg D
    Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A shortened insulin with full in vitro potency.
    Fischer WH; Saunders D; Brandenburg D; Wollmer A; Zahn H
    Biol Chem Hoppe Seyler; 1985 May; 366(5):521-5. PubMed ID: 3890892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new semisynthesis of human insulin.
    Obermeier R; Geiger R
    Hoppe Seylers Z Physiol Chem; 1976 Jun; 357(6):759-67. PubMed ID: 955572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of Fmoc-Lys(Pac)-OH and penicillin G acylase in the preparation of novel semisynthetic insulin analogs.
    Záková L; Zyka D; Jezek J; Hanclová I; Sanda M; Brzozowski AM; Jirácek J
    J Pept Sci; 2007 May; 13(5):334-41. PubMed ID: 17436342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of two LysB29 specifically labelled fluorescent derivatives of human insulin.
    Ciencialová A; Záková L; Jirácek J; Barthová J; Barth T
    J Pept Sci; 2004 Jul; 10(7):470-8. PubMed ID: 15298182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semisynthesis of insulin: specific activation of the arginine carboxyl group of the B chain of desoctapeptide-(B23--30)-insulin (bovine).
    Canova-Davis E; Carpenter FH
    Biochemistry; 1981 Nov; 20(24):7053-8. PubMed ID: 7032587
    [No Abstract]   [Full Text] [Related]  

  • 17. FTIR studies of secondary structures of bovine insulin and its derivatives.
    Wei JA; Lin YZ; Zhou JM; Tsou CL
    Biochim Biophys Acta; 1991 Oct; 1080(1):29-33. PubMed ID: 1932079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
    Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
    Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of reaction rates in trypsin-catalysed transamidation of porcine insulin and its B29-arginine analogue.
    Cao QP; Zhang YS; Geiger R
    Biol Chem Hoppe Seyler; 1988 Apr; 369(4):283-7. PubMed ID: 3041989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin.
    Inouye K; Watanabe K; Tochino Y; Kanaya T; Kobayashi M; Shigeta Y
    Experientia; 1981; 37(8):811-3. PubMed ID: 7026270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.